Cite
HARVARD Citation
Xie, H. et al. (2022). FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential. Expert opinion on investigational drugs. pp. 393-400. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, H. et al. (2022). FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential. Expert opinion on investigational drugs. pp. 393-400. [Online].